[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Immunology](https://durgical.com/en/immunology/) › [Adaptive immunity](https://durgical.com/en/immunology/areas/adaptive/) › Turning antibody responses off: antibody feedback and FcγRIIB

# Turning antibody responses off: antibody feedback and FcγRIIB

- Process

Once enough IgG has been made, that IgG tells B cells to slow down; the same brake helps explain how immunoglobulin therapies calm disease.

Updated Nov 15, 2026

## Key points

- IgG–antigen complex + BCR + FcγRIIB on the same B cell = stop signal (antibody feedback).
- FcγRIIB → ITIM → SHIP phosphatase; CD22 → SHP-1.
- [Anti-D immunoglobulin](https://durgical.com/en/pharmacology/anti-d-immunoglobulin/) prevents Rh sensitisation.
- Weak inhibitory receptors predispose to lupus.

## What it is

Antibody responses decline as antigen is cleared, but B cells also have inhibitory receptors that actively damp signalling. When IgG–antigen complexes bind the B-cell receptor and the inhibitory Fc receptor FcγRIIB at the same time, the B cell receives a stop signal: antibody feedback. CD22 sets a threshold for activation. Weak brakes predispose to autoimmunity, and therapeutic [immunoglobulins](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/) use some of these mechanisms.

## How to think about it

The finished product switches off the factory: IgG bound to antigen engages the BCR (go) and FcγRIIB (stop) on the same B cell at once, and the stop wins. It is negative feedback, like a thermostat, and only works when both receptors are touched by the same complex.

## Key facts

- FcγRIIB is the only inhibitory Fcγ receptor; the others (FcγRI, IIA, III) activate cells through ITAMs.
- Antibody feedback is one reason why the response to a vaccine slows as antibody levels climb.
- Variants of FcγRIIB that weaken inhibition are associated with lupus susceptibility.

## Step by step

- As IgG accumulates, it forms complexes with remaining antigen.
- The antigen part binds the BCR while the IgG Fc binds FcγRIIB on the same B cell.
- FcγRIIB carries an ITIM that recruits the phosphatase SHIP.
- SHIP removes lipid signals needed for BCR activation, so the B cell is inhibited.
- CD22, an inhibitory sialic-acid-binding receptor, recruits SHP-1 and raises the activation threshold.
- Regulatory T cells (including follicular regulatory T cells) further limit germinal-centre responses.

## Go and stop signals on a B cell

| Feature | Activating (BCR, CD19–CD21) | Inhibitory (FcγRIIB, CD22) |
| --- | --- | --- |
| Motif on the tail | ITAM | ITIM |
| Enzyme recruited | Kinases (Lyn, Syk, BTK, PI3K) | Phosphatases (SHIP via FcγRIIB, SHP-1 via CD22) |
| What engages it | Antigen; C3d-coated antigen via CD21 | IgG–antigen complexes (FcγRIIB); sialic acid on self cells (CD22) |
| Net effect | Lowers the activation threshold | Raises the threshold, ends the response |
| When it fails | BTK loss → XLA (no B cells) | Weak FcγRIIB → lupus susceptibility |

## Clinical notes

- Anti-D immunoglobulin given to an Rh-negative mother prevents her from becoming sensitised to fetal Rh-positive red cells; clearance of fetal cells and Fc-receptor-mediated suppression are proposed mechanisms.
- High-dose intravenous immunoglobulin dampens inflammation partly through inhibitory Fc receptor effects and by saturating FcRn, which speeds the removal of pathogenic IgG.
- Mice lacking inhibitory B-cell signalling molecules develop lupus-like autoimmunity, showing these brakes protect against self-reactivity.

## Common traps

- **All Fcγ receptors activate cells**: FcγRIIB is the only inhibitory one, carrying an ITIM instead of an ITAM.
- **Antibody responses stop only because antigen runs out**: IgG feedback through FcγRIIB and CD22 brakes actively damp B cells too.
- **Anti-D immunoglobulin treats [haemolytic disease of the newborn](https://durgical.com/en/pediatrics/haemolytic-disease-of-the-newborn-abo-and-rh-incompatibility/)**: it prevents maternal sensitisation and is useless once anti-D antibodies exist.

## Test yourself

Think of the answer, then tap the question to see it.

## Why does IgG bound to antigen inhibit a B cell, while free IgG does not?

Only a complex can bridge the BCR (via the antigen) and FcγRIIB (via the Fc) on the same cell, bringing SHIP to the BCR signal.

## Mice lacking FcγRIIB develop lupus-like disease. What does this show?

That inhibitory receptors restrain self-reactive B cells; weakening the brake lets autoantibody responses expand.

## An Rh-negative mother already has anti-D antibodies. Will anti-D immunoglobulin help now?

No. It works only before sensitisation, by clearing fetal Rh-positive cells and suppressing the response; once she makes anti-D it cannot reverse it.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/immunology/turning-antibody-responses-off-antibody-feedback-and-fc-riib/)

## Connections

## Related 7

- [B-cell activation, class switching and affinity maturation](https://durgical.com/en/immunology/b-cell-activation-class-switching-and-affinity-maturation/)
- [Fc receptors, BCR and TCR](https://durgical.com/en/immunology/fc-receptors-bcr-and-tcr/)
- [ABO and Rh blood groups, hemolytic disease of the newborn](https://durgical.com/en/immunology/abo-and-rh-blood-groups-hemolytic-disease-of-the-newborn/)
- [Regulatory T cell (Treg, FOXP3)](https://durgical.com/en/immunology/regulatory-t-cell/)
- [BCR signalling and the CD19–CD21 coreceptor](https://durgical.com/en/immunology/bcr-signalling-and-the-cd19-cd21-coreceptor/)
- [Treating antibody diseases: IVIG, plasma exchange, B-cell depletion](https://durgical.com/en/immunology/treating-antibody-diseases-ivig-plasma-exchange-b-cell-depletion/)
- [Extrafollicular and germinal-centre B-cell responses](https://durgical.com/en/immunology/extrafollicular-and-germinal-centre-b-cell-responses/)

## Related conditions 1

- [Systemic lupus erythematosus](https://durgical.com/en/conditions/systemic-lupus-erythematosus/)

## In Pharmacology 1

- [Normal human immunoglobulin (IVIG)](https://durgical.com/en/pharmacology/normal-human-immunoglobulin/)

[← All of immunology](https://durgical.com/en/immunology/)

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: [Rh incompatibility](https://medlineplus.gov/ency/article/001600.htm) (MedlinePlus, US National Library of Medicine, 2024); [Antibody](https://medlineplus.gov/ency/article/002223.htm) (MedlinePlus, US National Library of Medicine, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/immunology/turning-antibody-responses-off-antibody-feedback-and-fc-riib/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/immunology/turning-antibody-responses-off-antibody-feedback-and-fc-riib/
